組織微陣列市場規模、佔有率及成長分析（按流程、技術、最終用戶和地區）－2025-2032 年產業預測

預計 2023 年全球組織微陣列市場規模將達到 113 億美元，並從 2024 年的 124.5 億美元成長到 2032 年的 270.8 億美元，預測期內（2025-2032 年）的複合年成長率為 10.2%。

組織微陣列市場正經歷顯著成長，這得益於其在藥物研發中日益重要的角色以及製藥和生物技術產業的持續技術創新。癌症發生率的上升以及對精準、經濟高效診斷的需求，進一步推動了該市場的發展。組織微陣列技術能夠對多個組織樣本進行高通量分析，並已被證明對科學研究和臨床診斷都至關重要。生物標記檢驗和降低實驗室成本等優勢使其在醫學研究和個人化醫療開發中的應用日益廣泛。然而，高昂的初始設置成本、優質組織樣本獲取管道有限、數據解讀複雜以及對熟練專家的需求等挑戰可能會阻礙市場擴張，尤其是在資源有限的新興市場。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究

組織微陣列市場規模（按程序）

• 市場概覽
• 免疫組織化學
• 螢光原位雜合反應（FISH）
• 原位雜合技術
• 其他類型的程式

組織微陣列市場規模（依技術）

• 市場概覽
• 聚合酵素鏈鎖反應（PCR）
• 次世代定序
• DNA微陣列
• 其他類型的技術

組織微陣列市場規模（依最終用戶分類）

• 市場概覽
• 製藥和生物技術公司
• 研究機構

組織微陣列市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• OriGene Technologies
• ProteoGenex
• PREMIER Biosoft
• Biocompare
• US Biolab
• Arrayit Corporation
• Protein Biotechnologies
• BioCat GmbH
• SunLink Bioscience, Inc.
• Bio SB

結論和建議

Global Tissue Microarray Market size was valued at USD 11.3 billion in 2023 and is poised to grow from USD 12.45 billion in 2024 to USD 27.08 billion by 2032, growing at a CAGR of 10.2% during the forecast period (2025-2032).

The tissue microarray market is experiencing significant growth, driven by its expanding role in drug discovery and ongoing innovations in the pharmaceutical and biotech industries. The rising incidence of cancer, coupled with the demand for accurate and cost-effective diagnostics, further propels this market forward. Tissue microarray technology enables high-throughput analysis of multiple tissue samples, proving essential for both research and clinical diagnostics. Its advantages, including biomarker validation and cost reduction in laboratory expenses, contribute to its increasing use in medical research and personalized medicine development. However, challenges such as high initial setup costs, limited access to quality tissue samples, complex data interpretation, and the need for skilled professionals may impede market expansion, particularly in developing regions with limited resources.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Microarray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Microarray Market Segments Analysis

Global Tissue Microarray Market is segmented by Procedure, Technology, End-User and region. Based on Procedure, the market is segmented into Immunohistochemistry, Fluorescence in situ hybridization (FISH), In Situ Hybridization and Other Procedure Types. Based on Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing, DNA Microarray and Other Technology Types. Based on End-User, the market is segmented into Pharmaceutical and Biotechnological Companies and Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Microarray Market

The Global Tissue Microarray market is significantly driven by the extensive use of tissue microarrays (TMAs) in drug development processes, enabling the simultaneous screening of numerous tissue samples. By facilitating scientists' observations of diverse tissue responses to innovative drug compounds, TMAs play a crucial role in expediting target validation and toxicity assessment. This capability for high-throughput analysis has solidified TMAs as essential tools in the quest to develop safer and more effective therapies, ultimately enhancing the drug discovery pipeline and improving patient outcomes. Thus, their integral function in research and development continues to propel market growth.

Restraints in the Global Tissue Microarray Market

The Global Tissue Microarray market faces significant constraints primarily due to the limited availability of well-preserved, diverse, and standardized tissue samples, which hampers the overall efficiency of microarray techniques. Inconsistent sample quality stemming from variability undermines the accuracy of results and slows down research advancements. This challenge is particularly acute in the context of rare diseases and underrepresented populations, where sourcing reproducible and high-quality tissue samples proves to be a substantial obstacle. The lack of reliable tissue sources directly impacts the reliability of findings and the pace of scientific progress in this field.

Market Trends of the Global Tissue Microarray Market

The Global Tissue Microarray market is poised for significant transformation, driven by the integration of AI and digital pathology technologies. Over the next few years, advancements in automated pattern recognition and predictive modeling will enhance tissue microarray analysis, enabling quicker and more accurate diagnostics. This shift will not only minimize reliance on manual interpretation but will also make tissue microarrays more accessible to smaller hospitals and laboratories, thereby increasing research scalability. As a result, the market is expected to witness a surge in demand, fostering innovation and expanding its applications across diverse biomedical research fields and clinical diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Tissue Microarray Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• Immunohistochemistry
• Fluorescence in situ hybridization (FISH)
• In Situ Hybridization
• Other Procedure Types

Global Tissue Microarray Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• DNA Microarray
• Other Technology Types

Global Tissue Microarray Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnological Companies
• Research Organizations

Global Tissue Microarray Market Size & CAGR (2025-2032)

• North America (Procedure, Technology, End-User)
  • US
  • Canada
• Europe (Procedure, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure, Technology, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• OriGene Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProteoGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PREMIER Biosoft
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocompare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• US Biolab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayit Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Protein Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunLink Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations